Summary: MDMA researcher Mat Hoskins speaks at Breaking Convention 2015 in London, UK, about the upcoming MAPS-sponsored fMRI brain imaging study of the effects of MDMA on subjects diagnosed with treatment-resistant posttraumatic stress disorder (PTSD).
Originally appearing here.